ArticleDiscover oncology2025

Study on the molecular mechanism of UBA52 and BARD1 regulating hepatocellular carcinoma through the PI3 K/AKT signaling pathway.

Chenrui Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.